Key points are not available for this paper at this time.
Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2012.44.4281 Journal of Clinical Oncology - published online before print October 8, 2012 PMID: 23045586 Targeting B-Cell Receptor Signaling for Anticancer Therapy: The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Induces Impressive Responses in B-Cell Malignancies Adrian WiestnerxAdrian WiestnerSearch for articles by this author Show More National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD https://doi.org/10.1200/JCO.2012.44.4281 First Page Full Text PDF Figures and Tables Supplements © 2012 by American Society of Clinical Oncology
Adrian Wiestner (Tue,) studied this question.